PNC Financial Services Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15K | Sell |
127
-81
| -39% | -$3.28K | ﹤0.01% | 4121 |
|
|
2025
Q1 | $10.7K | Sell |
208
-2
| -1% | -$103 | ﹤0.01% | 3806 |
|
|
2024
Q4 | $11.6K | Buy |
210
+30
| +17% | +$1.66K | ﹤0.01% | 3743 |
|
|
2024
Q3 | $5.92K | Buy |
180
+13
| +8% | +$428 | ﹤0.01% | 3989 |
|
|
2024
Q2 | $4.54K | Sell |
167
-11
| -6% | -$299 | ﹤0.01% | 4018 |
|
|
2024
Q1 | $6.47K | Buy |
178
+173
| +3,460% | +$6.29K | ﹤0.01% | 3886 |
|
|
2023
Q4 | $101 | Buy |
+5
| New | +$101 | ﹤0.01% | 4520 |
|